Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000008

Director sold 6,901 shares at $50.00 ($345,050)

  • Director acquired 6,901 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +6,901 $14.33 $98,891 19,447 D
2026-04-06 Sale : show line 2 in the form 10b5-1 −6,901 $50.00 $345,050 12,546 D
Open-market sales · 6,901 sh · avg $50.00 · $345,050

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-06 Exercise or conversion : show line 3 in the form 10b5-1 Share Option −6,901 26,336 D
Loading xslF345X06/form4-04082026_080443.xml…